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Abstract
Background: Indocyanine green (ICG) dye is commonly used to stain the inner limiting membrane
during macular surgery. There are reports documenting the toxicity of ICG on retinal pigment
epithelial cells, with conflicting results in retinal ganglion cells. In the present study, we evaluated
the effect of ICG on retinal ganglion cells in vitro.
Cultured rat retinal ganglion cells (RGC-5) were exposed to different concentrations of ICG (0.25,
0.5, 1.0, 1.25, & 5 mg/ml) and at various time intervals (1, 5, 15, 30, & 60 minutes). Changes in
structural morphology were identified using phase contrast bright field microscopy. Cell viability
was quantified using the neutral red assay and cell death was characterized using Annexin-V
staining.
Findings: Significant morphologic changes were observed at the 15 and 60 min intervals for all
concentrations, where a reduction in cell size and loss of normal spindle shape was noted. A dose
dependent decrease in cell viability was observed with increasing concentration of ICG as well as
increasing exposure intervals. Compared to control, 48-74% reduction in neutral red uptake at all
concentrations for exposures 5 min or greater (p < 0.001). Even at 1 min exposure, a dose
dependent decline was observed in cell viability, with a 28-48% decline for doses above 1.25 mg/ml
(p = 0.007). Staining with Annexin-V, demonstrated a similar dose and time dependent increase in
number of cells exhibiting early apoptosis. A greater than two-fold increase in Annexin-V
expression for all doses at exposures greater than 1 min was noted.
Conclusion: ICG dye exhibits toxicity to retinal ganglion cells at clinically relevant doses following
1 min exposure.
Background
Indocyanine green (ICG) is commonly used to stain the
internal limiting membrane (ILM) [1,2] during macular
surgery for the treatment of idiopathic macular holes [3-
5] and diffuse diabetic macular edema [6]. However, the
safety of intravitreal use of ICG is not well established.
Adverse effects such as visual field defects [7-9] and atro-
phy of the retinal ganglion cell layer [10] subsequent to
ICG assisted membrane peeling have been reported. The
underlying cause of ICG-related adverse effects has been
proposed to be due to the osmolarity of the solution [11]
or photochemical damage [12].
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contact with ICG dye used for staining in macular surgery
and theoretically has the maximum exposure to the dye. A
number of animal and in-vitro studies have evaluated the
toxicity of ICG in cell culture models [13-18]. However,
there is conflicting data with regards to presence of ICG
mediated toxicity.
In this study, we investigated the effect of different ICG
concentrations at specific time intervals on rat RGCs
(RGC-5), in vitro, to establish a safe dose for use in-vivo.
We specifically evaluated the effect of ICG on morphol-
ogy, cell viability, and mechanism of cell death.
Methods
Cell Culture
Rat retinal ganglion cells (RGC-5) were graciously
donated by Dr. Neeraj Agarwal, University of North Texas.
RGC-5 cells were maintained in log-rhythmic growth and
cultured in Dulbecco's modified Eagle's medium (DMEM:
L-glutamine, 110 mg/L sodium bicarbonate and 1 g/L D-
glucose) containing 10% fetal bovine serum (JRH Bio-
sciences, Lenexa, Ka) and 100 U/ml of penicillin and 100
μg/ml of streptomycin. The cells were maintained in 75
cm2 filter-capped cell culture flasks and incubated with
5% CO2 at 37°C.
ICG Preparation
25 mg of ICG (Acorn, IL) was diluted in 5 ml phosphate-
buffered saline with albumin (PBSA) to obtain a 5 mg/ml
mixture. The prepared solution was further diluted to
obtain ICG concentrations of 0.25, 0.5, 1.0, 1.25, and 5
mg/ml. ICG solution was prepared fresh for each experi-
ment. The osmolarity of the prepared ICG solutions
ranged between 309 and 313 mosm/litre.
ICG Staining
The RGCs were grown in 24-well culture plates (Corning,
Corning, NY) for 24 hours in conditioned cell culture
media. The culture medium was aspirated from each of
the 24-well culture plates and replaced with the various
ICG concentrations. RGCs were exposed to the various
concentrations of ICG (0, 0.25, 0.5, 1.0, 1.25 and 5 mg/
ml) for 1, 5, 15, 30 and 60 minutes. Cultures containing
PBSA alone served as control. Following exposure to ICG
dye, cells were washed with PBS and were subsequently
cultured for 2 hours in DMEM, at which point the experi-
ments were concluded.
Structural Morphology
Glass cover slips with RGC cells exposed to different ICG
concentrations (0, 0.25, 0.5, 1.0, 1.25, 5 mg/ml) were
washed twice with PBS and mounted on a slide using crys-
tal mount solution. The slides were analyzed by bright
field microscopy (Olympus U-RFL-T) to identify morpho-
logical changes.
Cell viability by Neutral Red (NR) Uptake Assay
The NR uptake assay was done as previously described
[19]. Briefly, NR working solution (0.033%) was freshly
prepared for each experiment by diluting 1 ml of NR stock
solution (0.5% (Sigma Aldrich, St. Louis, MO) in 14.5 ml
of DEPC (Sigma Aldrich, St. Louis, MO). After ICG expo-
sure, an equal volume of fresh media supplemented the
ICG solution containing 33 μl of NR working solution.
The cells were allowed to incubate at room temperature
(RT) for 2 h. After incubation, the NR solution was aspi-
rated and the attached cells were washed twice with PBS,
before allowing too air-dry at RT for 20 minutes. The cells
were treated with ice-cold solubilization buffer (1% acetic
acid/50% ethanol; 300 μL) to release the remaining NR
from the internal compartments of the cell for 30 min-
utes. The absorbance was measured at 490 nm using a
Bio-Tek ELX 800 microplate reader.
Evaluation of Apoptosis with Flow Cytometry
8 × 103 RGC-5 cells were isolated and centrifuged. Cells
were then washed twice with PBS and resuspended in 1×
binding buffer (10 mM HEPES/NaOH, 140 mM NaCl,
and 2.5 mM CaCl2, pH 7.5). 500 μl of each experimental
cell suspension was added to different tubes and stained
with 5 μl of Annexin V-FITC. After incubating the tubes at
room temperature for 10 minutes, the fluorescence was
analyzed by flow cytometry (Epics XL-MLC, Becton Dick-
inson, Mountain View, CA). The 0.25, 0.50, and 1.0 mg/
ml concentrations of ICG were evaluated.
Statistical analysis
Statistical analysis of the data was done using Student's t
test (Graphpad Prizm, Version3, CA, US). A p value of less
than 0.05 was considered significant.
Results
Cell Morphology
After 1 and 5-minute incubation at all ICG concentra-
tions, the cells continued to show similar structural fea-
tures compared to controls. However, there was a
significant morphological variation after 15 and 60-
minute incubation, at all concentrations. The cells
assumed an oval shape and were reduced in size com-
pared with longer spindle shaped control. (Figure 1)
Cell Viability Assay (Neutral Red)
RGC cells exposed to concentrations as low as 0.25 & 0.5
mg/ml demonstrated reduced NR uptake as early as 1
min. A 12 and 14% reduction in cell viability was noted
respectively. At the same exposure time, the 1.0 & 1.25
mg/ml doses, demonstrated a 21 and 28% reduction, withPage 2 of 5
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0.007).
After 5 min exposure, the lowest concentration group,
reduced cell viability by 48% compared with control. This
trend continued with either an increase in dose or expo-
sure time. The greatest reduction in cell viability was
observed at the highest concentration at the longest expo-
sure, where only 17.5% of the remaining cells were viable
(p < 0.001) (Figure 2).
Flow Cytometry
Flow cytometric analysis, revealed a parallel increase in
Annexin-V detection compared with the results of the
neutral red assay. Following 1 min exposure, both 0.25
and 0.50 mg/ml concentrations, demonstrated a 45%
increase in apoptotic cells compared with control. Similar
to the results from the cell viability assay, increased dura-
tion at the lowest concentration, correlated with a 2.5 fold
increase in percentage of apoptotic cells.
The greatest separation among the various doses was evi-
dent at 15 min exposure interval. The 0.25 mg/ml concen-
tration maintained a 2.5 fold increase in apoptotic cells,
Morphologic changes following exposure to ICG dyeFigure 1
Morphologic changes following exposure to ICG dye. Representative images at 0.5 mg/ml concentration were obtained 
with phase contrast microscopy. Cells became rounder and smaller with increasing duration of exposure.
Cell viability evaluated by Neutral Red assay, demonstrates a dose and time dependent decrease in cell viability following ICG exposureFigure 2
Cell viability evaluated by Neutral Red assay, demonstrates a dose and time dependent decrease in cell viabil-
ity following ICG exposure. Data expressed as percent of control.Page 3 of 5
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mg/ml concentrations respectively. A similar relationship
was maintained across the various doses for the remaining
exposure times. (Figure 3)
Discussion
Indocyanine green (ICG) is an amphillic tricarbocyanine
dye often used in macular surgery, where it stains the
internal limiting membrane and facilitates its removal [1-
6]. Both clinical [7-10] and experimental [11-17] reports
have documented toxicity of ICG dye. However, there is a
lack of standardization with regards to doses tested and
exposure times evaluated. This study addresses this ques-
tion by testing different concentrations (including the
concentrations used in clinical setting: 0.25 and 0.5 mg/
ml) at different exposure times, while adding to the body
of literature relating to the mechanism of ICG mediated
cell death.
Morphologic analysis demonstrated the toxic effects of
ICG on retinal ganglion cells where evidence of toxicity
was observed with increased exposure time. This becomes
clinically relevant in cases of incomplete ICG removal or
post surgical persistence of the dye [20]. These results were
further supported by loss of cell viability in a dose and
time dependent manner, where ICG toxicity was observed
at the lowest concentration after 1 min exposure. It has
been suggested that 1.25 mg/ml, provides the optimal vis-
ibility of the ILM in clinical settings [21]. Our study dem-
onstrated 29% reduction in cell viability at this
concentration, following 1 min exposure. This is corrobo-
rated by clinical studies which have reported visual filed
defects after in-vivo use of 0.05% ICG for 1 minute during
vitrectomy for macular hole surgery [7,9].
Mechanistic studies have revealed that exposure to ICG
results in apoptosis in the retinal cells [17]. In our study,
we used Annexin-V, a human anticoagulant that has
strong attraction for phoshatidylserine residues, to detect
apoptosis in the RGC cell line. Our results indicated as
both time and concentration increased, the detection of
Annexin-V increased. For doses = 0.50 mg/ml, 1 minute
exposure resulted in approximately 50% increase in apop-
tosis. However, at exposure time of 5 minutes, significant
cell loss (>2-fold) was observed irrespective of the concen-
tration of the dye used. These results mirrored the loss in
cell viability using the neutral red (NR) assay.
The limitation of the study is the use of an in-vitro model
which does not factor the penetrability of ICG across the
ILM.
Conclusion
Our work illustrates worsening cytotoxic effects of ICG to
retinal ganglion cells in a dose and time-dependent man-
ner. In addition, we have shown that cytotoxic effect
occurs in the absence of any stimulating light. We suggest
that the lower concentration and shorter staining time of
ICG be used for staining ILM during vitrectomy. Com-
plete and quick removal after injection over the macula is
imperative to prevent detrimental changes to the retinal
ganglion cells.
Annexin-V detection evaluated by flow cytometry, demonstrates a dose and time dependent increase in early apoptosis follow-ing ICG exposureFi ure 3
Annexin-V detection evaluated by flow cytometry, demonstrates a dose and time dependent increase in early 
apoptosis following ICG exposure. Data expressed as percent of control.Page 4 of 5
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